Ventas, Inc. Stock

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse 16:00:01 2024-06-24 EDT 5-day change 1st Jan Change
50.69 USD +0.54% Intraday chart for Ventas, Inc. +1.38% +1.71%
Sales 2024 * 4.84B 6.6B Sales 2025 * 5.12B 6.99B Capitalization 20.48B 27.94B
Net income 2024 * 12M 16.37M Net income 2025 * 133M 181M EV / Sales 2024 * 6.9 x
Net Debt 2024 * 12.89B 17.58B Net Debt 2025 * 12.86B 17.55B EV / Sales 2025 * 6.51 x
P/E ratio 2024 *
586 x
P/E ratio 2025 *
160 x
Employees 486
Yield 2024 *
3.59%
Yield 2025 *
3.76%
Free-Float 99.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.54%
1 week+1.38%
Current month+0.86%
1 month+6.72%
3 months+16.90%
6 months+1.58%
Current year+1.71%
More quotes
1 week
49.76
Extreme 49.76
50.90
1 month
46.66
Extreme 46.66
50.90
Current year
41.45
Extreme 41.45
50.90
1 year
39.33
Extreme 39.33
50.99
3 years
35.33
Extreme 35.33
64.02
5 years
13.35
Extreme 13.345
75.40
10 years
13.35
Extreme 13.345
81.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 98-12-31
Director of Finance/CFO 56 14-10-26
Chief Tech/Sci/R&D Officer - 19-01-24
Members of the board TitleAgeSince
Director/Board Member 60 22-03-06
Director/Board Member 63 11-05-11
Director/Board Member 55 20-07-05
More insiders
Date Price Change Volume
24-06-24 50.69 +0.54% 2,851,046
24-06-21 50.42 +0.70% 4,803,134
24-06-20 50.07 -0.38% 1,454,382
24-06-18 50.26 +0.52% 1,413,090

Delayed Quote Nyse, June 24, 2024 at 04:00 pm

More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
50.69 USD
Average target price
54.56 USD
Spread / Average Target
+7.63%
Consensus